Past research on the relationships between SHBG and NAFLD has often been performed in patients with metabolic disorders [11–16], and the results showed that serum SHBG levels were lower in NAFLD patients with metabolic disorders than in those without NAFLD. Here, SHBG is linked to metabolic dysfunction-associated steatotic liver disease.